Zevalin yttrium (90Y) intravenous injection set (YJ code: 4291414G1020, standard: 1 set) from Mundipharma contains Ibritumomab Tiuxetan (genetical recombination) and Yttrium chloride (90Y). It is a radiotherapeutic monoclonal antibody used in combination with rituximab to treat B-cell non-Hodgkin’s lymphoma (NHL), particularly relapsed or refractory low-grade or follicular NHL.
Zevalin yttrium (90Y) intravenous injection set
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →